Pharmaceutical Name
Borrelia burgdorferi Bacterin 

• Broad protection: Lyme vaccine with isolates from two seroprotective groups (S-1-10 and C-1-11).

• Covers all outer surface proteins (Osp) for development of protective immunity.

• Developed from whole-cell B. burgdorferi.

• Proven one year duration of immunity in a challenge study.

• Natural Tick Challenge. 

Indications
This bacterin is for the vaccination of healthy dogs against disease caused by Borrelia burgdorferi. 
 
Dosage
For further information including dose rate and complete directions and warnings, please see the Product Label by clicking here.
 
Galaxy^® Lyme is a registered trademark of Schering-Plough Animal Health Corporation.